← All trials
NCT01680679
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2012
- Primary completion
- May 1, 2014
- Completion date
- May 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 18163
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- University of Colorado, DenverLead sponsor
- University of Colorado, DenverOverall official - principal investigator
- International Clinical Epidemiology Network (INCLEN) TRUSTCollaborator
- All India Institute of Medical SciencesOverall official - principal investigator
- All India Institute of Medical SciencesCollaborator
- University of Alabama, BirminghamCollaborator
- Centers for Disease Control and Prevention (CDC)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.